Evoclin clindamycin: Phase IV data

Data from an open-label, Phase IV trial in 30 patients showed that 1 and 2 weeks treatment with 1% clindamycin foam resulted in complete clearance in 73.3% and 86.7% of patients at the end of treatmen...